Oncoinvent ASA (ONCIN) — Financial Flexibility Index

Latest as of June 2025: -3.74x

Oncoinvent ASA (ONCIN) has a Financial Flexibility Index of -3.74x as of June 2025. Free cash flow of Nkr-73.90 Million (operating CF Nkr-73.90 Million minus capex Nkr0.00) represents -4% of total liabilities (Nkr19.75 Million). Also explore net asset momentum of Oncoinvent ASA to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-3.74x
Free Cash Flow / Total Liabilities

Free Cash Flow

Nkr-73.90 Million
Operating CF − Capex

Total Liabilities

Nkr19.75 Million
NOK

Capital Expenditures

Nkr0.00
NOK

Oncoinvent ASA Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for Oncoinvent ASA across 5 annual periods. Check asset allocation strategy of Oncoinvent ASA to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Oncoinvent ASA (2021–2025)

Year-by-year free cash flow to debt coverage for Oncoinvent ASA. For the full company profile including market capitalisation, see ONCIN company net worth.

Year Flexibility Index Free Cash Flow (NOK) Operating CF Total Liabilities YoY Change
2025 -2.24x Nkr-131.07 Million Nkr-131.19 Million Nkr58.63 Million ▲ +7.5%
2024 -2.42x Nkr-151.44 Million Nkr-153.24 Million Nkr62.68 Million ▼ -1.7%
2023 -2.37x Nkr-111.29 Million Nkr-138.11 Million Nkr46.86 Million ▲ +34.7%
2022 -3.63x Nkr-284.25 Million Nkr-288.23 Million Nkr78.21 Million ▲ +21.2%
2021 -4.61x Nkr-303.34 Million Nkr-303.34 Million Nkr65.81 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities